POMDOCTOR Ltd (POM) Financial Ratios
4 years of historical data (2021–2024) · Healthcare · Medical - Pharmaceuticals
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
N/A
—
5yr avg: N/A
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
POM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
POMDOCTOR Ltd currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Market Cap | $8M | — | — | — | — |
| Enterprise Value | $72M | — | — | — | — |
| P/E Ratio → | -0.40 | — | — | — | — |
| P/S Ratio | 0.15 | — | — | — | — |
| P/B Ratio | — | — | — | — | — |
| P/FCF | — | — | — | — | — |
| P/OCF | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
POM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — |
| EV / FCF | — | — | — | — | — |
POM Profitability
Margins and return-on-capital ratios measuring operating efficiency
POMDOCTOR Ltd earns an operating margin of -7.5%. Operating margins have compressed from -1.5% to -7.5% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Gross Margin | 13.9% | 13.9% | 12.7% | 22.4% | 24.4% |
| Operating Margin | -7.5% | -7.5% | -7.3% | -1.5% | -37.0% |
| Net Profit Margin | -41.9% | -41.9% | -47.7% | -51.2% | -87.5% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| ROE | — | — | — | — | — |
| ROA | -254.8% | -254.8% | -253.0% | -369.5% | -975.6% |
| ROIC | — | — | — | — | — |
| ROCE | — | — | — | — | — |
POM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $433M ($441M total debt minus $8M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — |
| Net Debt / Equity | — | — | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — |
| Interest Coverage | -1.99 | -1.99 | -1.61 | -0.22 | -4.89 |
POM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.21x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.33x to 0.21x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Current Ratio | 0.21 | 0.21 | 0.35 | 0.33 | 0.17 |
| Quick Ratio | 0.16 | 0.16 | 0.27 | 0.28 | 0.09 |
| Cash Ratio | 0.04 | 0.04 | 0.04 | 0.02 | 0.02 |
| Asset Turnover | — | 7.41 | 4.60 | 5.04 | 11.15 |
| Inventory Turnover | 32.17 | 32.17 | 20.96 | 23.23 | 20.06 |
| Days Sales Outstanding | — | 15.95 | 38.78 | 40.57 | 1.25 |
POM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
POMDOCTOR Ltd does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — |
| FCF Yield | — | — | — | — | — |
| Buyback Yield | 0.0% | — | — | — | — |
| Total Shareholder Yield | 0.0% | — | — | — | — |
| Shares Outstanding | — | $118M | $118M | $118M | $118M |
Peer Comparison
Compare POM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 POMYou | $8M | -0.4 | — | — | 13.9% | -7.5% | — | — | — |
 TDOC | $1B | -7.1 | 17.1 | 5.1 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 |
 AMWL | $141M | -1.4 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — |
 HIMS | $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
 DOCS | $4B | 20.9 | 16.8 | — | 89.1% | 33.3% | 19.3% | 19.8% | 0.0 |
 WELL | $145B | 148.7 | 64.6 | 50.8 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 |
 ALHC | $4B | -5908.1 | 93.4 | 39.5 | 12.4% | 0.4% | -0.5% | — | 7.5 |
 GDRX | $922M | 31.2 | 4.2 | 5.6 | 92.8% | 11.0% | 4.5% | 10.6% | 0.3 |
 PHVS | $2B | -9.7 | — | — | — | — | -65.2% | — | — |
 TALK | $873M | 130.3 | 138.6 | — | 43.0% | 1.4% | 6.6% | 3.9% | — |
 VEEV | $25B | 28.2 | 19.7 | 18.0 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 4 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
POM — Frequently Asked Questions
Quick answers to the most common questions about buying POM stock.
What is POMDOCTOR Ltd's P/E ratio?
POMDOCTOR Ltd's current P/E ratio is -0.4x. This places it at the 50th percentile of its historical range.
Is POM stock overvalued?
Based on historical data, POMDOCTOR Ltd is trading at a P/E of -0.4x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are POMDOCTOR Ltd's profit margins?
POMDOCTOR Ltd has 13.9% gross margin and -7.5% operating margin.